KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell ...

We have long struggled to determine how the first living organisms on Earth came together. Now, surprising evidence hints that poorly understood prions may have been the vital missing ingredient ...

As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander ...

New research shows that the brain uses built-in molecular timers to decide which memories last longer and which ones fade ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

And 4 other takeaways for life scientists from the ‘off-the-record’ Make America Healthy Again conference The MAHA (Make ...

Gene-edited crops are no safer than GMOs, and fast-tracking regulatory approval could trigger a costly backlash.

New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.

The CRISPR gene editing technique has had a dramatic influence on biomedical research, and has even been applied to a few ...